Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Laryngo- Rhino- Otologie
|
April 11, 2018
Jens Büntzel
Expert Review of Anticancer Therapy
|
March 12, 2009
Second-line chemotherapy in head and neck cancer: what should we expect?
Jens Büntzel, Oliver Micke
Journal of Cancer Research and Clinical Oncology
|
October 10, 2020
How to transfer traditional knowledge about medicinal herbs? or TCM plants: a black box for modern oncologists
Judith Büntzel, Oliver Micke, Jens Büntzel
Journal of Cancer Research and Clinical Oncology
|
February 13, 2023
"I do not hear you!": hearing-impaired cancer patients report their communication experiences
Maximilian Keck, Jutta Hübner, Jens Büntzel
Schmerz (Berlin, Germany)
|
May 8, 2023
[Complementary and alternative medicine-An option for chronic pain patients?]
Jutta Hübner, Christian Keinki, Jens Büntzel
International Journal of Colorectal Disease
|
January 20, 2026
Social and psychological effects of a stoma on the sexuality and self-image of patients
Marvin Fischer, Jens Büntzel, Jutta Hübner
Deutsches Arzteblatt International
|
May 28, 2019
High-Quality Studies in Complementary and Alternative Medicine are Necessary
Jutta Hübner, Oliver Micke, Jens Büntzel
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
September 18, 2022
Can Cancer Education Programs Improve Health Literacy Among Deaf and Hard of Hearing Patients: a Systematic Review
Jan Münstermann, Jutta Hübner, Jens Büntzel
Schmerz (Berlin, Germany)
|
September 20, 2023
[CAM procedures in pain therapy: an evidence-based discourse is needed]
Jutta Hübner, Christian Keinki, Jens Büntzel
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2003
Complementary and alternative medicine in radiotherapy patients--more harm than expected? In regard to D'Amico et al.: self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROBP 2002;54:1311-1313
Oliver Micke, Ralph Mücke, Klaus Schönekaes, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Laryngo- Rhino- Otologie
|
April 11, 2018
Jens Büntzel
Expert Review of Anticancer Therapy
|
March 12, 2009
Second-line chemotherapy in head and neck cancer: what should we expect?
Jens Büntzel, Oliver Micke
Journal of Cancer Research and Clinical Oncology
|
October 10, 2020
How to transfer traditional knowledge about medicinal herbs? or TCM plants: a black box for modern oncologists
Judith Büntzel, Oliver Micke, Jens Büntzel
Journal of Cancer Research and Clinical Oncology
|
February 13, 2023
"I do not hear you!": hearing-impaired cancer patients report their communication experiences
Maximilian Keck, Jutta Hübner, Jens Büntzel
Schmerz (Berlin, Germany)
|
May 8, 2023
[Complementary and alternative medicine-An option for chronic pain patients?]
Jutta Hübner, Christian Keinki, Jens Büntzel
International Journal of Colorectal Disease
|
January 20, 2026
Social and psychological effects of a stoma on the sexuality and self-image of patients
Marvin Fischer, Jens Büntzel, Jutta Hübner
Deutsches Arzteblatt International
|
May 28, 2019
High-Quality Studies in Complementary and Alternative Medicine are Necessary
Jutta Hübner, Oliver Micke, Jens Büntzel
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
September 18, 2022
Can Cancer Education Programs Improve Health Literacy Among Deaf and Hard of Hearing Patients: a Systematic Review
Jan Münstermann, Jutta Hübner, Jens Büntzel
Schmerz (Berlin, Germany)
|
September 20, 2023
[CAM procedures in pain therapy: an evidence-based discourse is needed]
Jutta Hübner, Christian Keinki, Jens Büntzel
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2003
Complementary and alternative medicine in radiotherapy patients--more harm than expected? In regard to D'Amico et al.: self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROBP 2002;54:1311-1313
Oliver Micke, Ralph Mücke, Klaus Schönekaes, et al.
Page
of 7